108 related articles for article (PubMed ID: 11481628)
1. Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice.
Lechmann M; Murata K; Satoi J; Vergalla J; Baumert TF; Liang TJ
Hepatology; 2001 Aug; 34(2):417-23. PubMed ID: 11481628
[TBL] [Abstract][Full Text] [Related]
2. Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates.
Jeong SH; Qiao M; Nascimbeni M; Hu Z; Rehermann B; Murthy K; Liang TJ
J Virol; 2004 Jul; 78(13):6995-7003. PubMed ID: 15194776
[TBL] [Abstract][Full Text] [Related]
3. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
[TBL] [Abstract][Full Text] [Related]
4. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
[TBL] [Abstract][Full Text] [Related]
5. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.
Revaz V; Zurbriggen R; Moser C; Schiller JT; Ponci F; Bobst M; Nardelli-Haefliger D
Antiviral Res; 2007 Oct; 76(1):75-85. PubMed ID: 17617476
[TBL] [Abstract][Full Text] [Related]
7. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
[TBL] [Abstract][Full Text] [Related]
8. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.
Encke J; zu Putlitz J; Stremmel W; Wands JR
Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses.
Qiao M; Murata K; Davis AR; Jeong SH; Liang TJ
Hepatology; 2003 Jan; 37(1):52-9. PubMed ID: 12500188
[TBL] [Abstract][Full Text] [Related]
10. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
Large MK; Kittlesen DJ; Hahn YS
J Immunol; 1999 Jan; 162(2):931-8. PubMed ID: 9916717
[TBL] [Abstract][Full Text] [Related]
11. Recombinant in vitro assembled hepatitis C virus core particles induce strong specific immunity enhanced by formulation with an oil-based adjuvant.
Acosta-Rivero N; Poutou J; Alvarez-Lajonchere L; Guerra I; Aguilera Y; Musacchio A; Rodríguez A; Aguilar JC; Falcon V; Alvarez-Obregon JC; Soria Y; Torres D; Linares M; Pérez A; Morales-Grillo J; Dueñas-Carrera S
Biol Res; 2009; 42(1):41-56. PubMed ID: 19621132
[TBL] [Abstract][Full Text] [Related]
12. Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).
Mihailova M; Boos M; Petrovskis I; Ose V; Skrastina D; Fiedler M; Sominskaya I; Ross S; Pumpens P; Roggendorf M; Viazov S
Vaccine; 2006 May; 24(20):4369-77. PubMed ID: 16574285
[TBL] [Abstract][Full Text] [Related]
13. Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
Liu M; Chen H; Luo F; Li P; Pan Q; Xia B; Qi Z; Ho WZ; Zhang XL
Vaccine; 2007 Sep; 25(36):6572-80. PubMed ID: 17675185
[TBL] [Abstract][Full Text] [Related]
14. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
[TBL] [Abstract][Full Text] [Related]
15. Expression and self-assembly of HCV structural proteins into virus-like particles and their immunogenicity.
Zhao W; Liao GY; Jiang YJ; Jiang SD
Chin Med J (Engl); 2004 Aug; 117(8):1217-22. PubMed ID: 15361298
[TBL] [Abstract][Full Text] [Related]
16. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
Siler CA; McGettigan JP; Dietzschold B; Herrine SK; Dubuisson J; Pomerantz RJ; Schnell MJ
Virology; 2002 Jan; 292(1):24-34. PubMed ID: 11878905
[TBL] [Abstract][Full Text] [Related]
17. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
Sugauchi F; Wang RY; Qiu Q; Jin B; Alter HJ; Shih JW
J Infect Dis; 2006 Feb; 193(4):563-72. PubMed ID: 16425136
[TBL] [Abstract][Full Text] [Related]
18. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
19. Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.
Desjardins D; Huret C; Dalba C; Kreppel F; Kochanek S; Cosset FL; Tangy F; Klatzmann D; Bellier B
J Gene Med; 2009 Apr; 11(4):313-25. PubMed ID: 19248137
[TBL] [Abstract][Full Text] [Related]
20. Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection.
Murata K; Lechmann M; Qiao M; Gunji T; Alter HJ; Liang TJ
Proc Natl Acad Sci U S A; 2003 May; 100(11):6753-8. PubMed ID: 12748380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
